SBIR/STTR Research Award
Life-Saving Mini Auto-Injector to Deliver Epinephrine
Award amount
$49,434Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- RX BANDZ, INC.
- Proposal award date
- 2021-04-14
- Contract end date
- 2021-07-19
- UEI
- DXRED7S6FVE9
- Solicitation number
- X21.1
- Topic code
- AF211-CSO1
Research abstract
x Bandz’ innovative MiniJect™ auto-injector can be adapted to deliver epinephrine to Active Duty and beneficiaries prone to allergic reactions (anaphylaxis), as well as medics providing epinephrine when treating shock, cardiac arrest or respiratory distress. Its reduced size, weight, and ease-of-use means users can administer the right dose more reliably and quickly, no longer having to carry bulky, inconvenient auto-injectors. Furthermore, Rx Bandz’ epinephrine formulation aims to provide an increased shelf life over current auto-injectors.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Shelf-life Extension for Emergency Medication
- Continue, Expand, and Refine Research and Development of a Hydromorphone Autoinjector
- Stop The Bleed - Save the Warfighter! : Intramuscular Auto-Injector Delivery of Tranexamic Acid (TXA) on the Battlefield
- Extended Utilization of Lifesaving Medications via Autoinjector
- Auto Injector Administration of Ketamine for Critically Injured Airmen
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Training the Ethical Employment of Lethal Autonomous Weapons (TEELAWS)
- Braided Ultra-High Temperature (UHT) Ceramic Matrix Composites (CMC) Scramjet Isolator Development
- SBIR Sequential Phase II (TACFI) Traditional Contract - Athenium Analytics Always Ahead
- Advanced Fielding and Deployment Dashboard Platform
- Starfish Space STRATFI
Research funding history
12 SBIR/STTR records share this UEI (2020–2023). Reported award amounts total $6,990,569. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Defense